Merck Recalls Zerbaxa Injection Vials Due to Sterility Test Failures
Merck Sharp & Dohme is recalling 106,503 vials of Zerbaxa (ceftolozane and tazobactam) injection because sterility tests on related batches failed.
- Product
- ZERBAXA — ZERBAXA (CEFTOLOZANE AND TAZOBACTAM)
- Category
- Drug
- Distribution
- Distributed nationwide